טוען...
Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
Cisplatin is a chemotherapeutic drug commonly used in clinics. However, acquired resistance confines its application in chemotherapeutics. To overcome the acquired resistance to cisplatin, it is reasoned, based on our previous findings of mediation of cellular responses by [Gd@C(82)(OH)(22)](n) nano...
שמור ב:
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
National Academy of Sciences
2010
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2867714/ https://ncbi.nlm.nih.gov/pubmed/20368438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0909707107 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|